Editorial: U.S. FDA’s Experience with COVID-19 Antibody Tests
Precision Vaccinations: An editorial published by The New England Journal of Medicine (NEJM) highlights ‘establishing robust and coordinated national and international mechanisms for generating evidence and gathering, sharing, and disseminating information will be critical to ending the current pandemic and addressing future public health emergencies.’‘Moving forward, the US Food and Drug Administration (FDA) will continue to take steps to ensure the timely availability of accurate and reliable antibody tests to meet the public health need as the pandemic evolves,’ wrote Jeffrey Shuren, M.